News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,787 Results
Type
Article (86712)
Company Profile (703)
Press Release (763370)
Multimedia
Podcasts (138)
Webinars (17)
Section
Business (232764)
Career Advice (4130)
Deals (39742)
Drug Delivery (129)
Drug Development (91054)
Employer Resources (198)
FDA (18154)
Job Trends (17353)
News (396682)
Policy (39791)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (101)
Alliances (56927)
ALS (112)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (184)
Approvals (18100)
Artificial intelligence (365)
Autoimmune disease (34)
Automation (18)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (374)
Cancer (2880)
Cardiovascular disease (232)
Career advice (3537)
Career pathing (34)
CAR-T (199)
CDC (33)
Cell therapy (546)
Cervical cancer (23)
Clinical research (73981)
Collaboration (1028)
Company closure (3)
Compensation (645)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (315)
Cystic fibrosis (116)
Data (2849)
Decentralized trials (2)
Denatured (48)
Depression (65)
Diabetes (327)
Diagnostics (6958)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (165)
Drug pricing (147)
Drug shortages (35)
Duchenne muscular dystrophy (121)
Earnings (97408)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131200)
Executive appointments (875)
FDA (19739)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (932)
Gene editing (141)
Generative AI (36)
Gene therapy (412)
GLP-1 (891)
Government (5222)
Grass and pollen (6)
Guidances (179)
Healthcare (20911)
Huntington's disease (29)
IgA nephropathy (39)
Immunology and inflammation (171)
Immuno-oncology (7)
Indications (36)
Infectious disease (3069)
Inflammatory bowel disease (162)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (114)
Interviews (813)
IPO (17882)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10126)
Liver cancer (83)
Lung cancer (408)
Lymphoma (197)
Machine learning (9)
Management (65)
Manufacturing (406)
MASH (91)
Medical device (14690)
Medtech (14695)
Mergers & acquisitions (22519)
Metabolic disorders (873)
Multiple sclerosis (100)
NASH (23)
Neurodegenerative disease (134)
Neuropsychiatric disorders (37)
Neuroscience (2235)
NextGen: Class of 2025 (7687)
Non-profit (5087)
Now hiring (46)
Obesity (461)
Opinion (285)
Ovarian cancer (96)
Pain (115)
Pancreatic cancer (108)
Parkinson's disease (185)
Partnered (25)
Patents (293)
Patient recruitment (140)
Peanut (53)
People (65569)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22849)
Phase II (32123)
Phase III (24186)
Pipeline (1597)
Policy (214)
Postmarket research (3552)
Preclinical (10313)
Press Release (72)
Prostate cancer (138)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (490)
Real estate (7397)
Recruiting (75)
Regulatory (26991)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (91)
Series A (159)
Series B (105)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (36)
Startups (4298)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (63)
The Weekly (88)
Vaccines (874)
Venture capitalists (51)
Weight loss (315)
Women's health (46)
Worklife (20)
Date
Today (27)
Last 7 days (524)
Last 30 days (2513)
Last 365 days (34736)
2025 (16326)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (278)
Arkansas (14)
Asia (50403)
Australia (8861)
California (7425)
Canada (2294)
China (674)
Colorado (319)
Connecticut (333)
Delaware (190)
Europe (115639)
Florida (1096)
Georgia (251)
Hawaii (1)
Idaho (65)
Illinois (708)
India (32)
Indiana (369)
Iowa (16)
Japan (217)
Kansas (115)
Kentucky (30)
Louisiana (17)
Maine (73)
Maryland (1062)
Massachusetts (5660)
Michigan (267)
Minnesota (463)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (72)
New Jersey (2069)
New Mexico (31)
New York (2081)
North Carolina (1207)
North Dakota (10)
Northern California (3203)
Ohio (242)
Oklahoma (16)
Oregon (48)
Pennsylvania (1588)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (34)
South Dakota (1)
Southern California (2736)
Tennessee (121)
Texas (1116)
United States (28036)
Utah (220)
Virginia (198)
Washington D.C. (79)
Washington State (658)
West Virginia (4)
Wisconsin (81)
There are 850,787 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
1 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 13, 2025
June 16, 2025
·
3 min read
Press Releases
Rakuten Medical Selected to Participate in FDA CEO Forum in San Diego
June 16, 2025
·
5 min read
Press Releases
DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals’ Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints
June 16, 2025
·
1 min read
Press Releases
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
June 16, 2025
·
10 min read
Press Releases
Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 16, 2025
·
8 min read
Press Releases
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
June 16, 2025
·
10 min read
Press Releases
Investigational combination of first-in-class bispecific antibodies TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
June 16, 2025
·
14 min read
Press Releases
Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne
June 16, 2025
·
12 min read
Press Releases
Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
June 16, 2025
·
29 min read
1 of 85,079
Next
